The Science of Glivec

Learn more about Glivec cutting edge molecularly-targeted treatment mechanism and its application in CML and GIST treatment regimens.

MOLECULAR TARGET

Helping Patients

Find out how Glivec is transforming the management and treatment of certain cancers, including CML and GIST.

HUMAN IMPACT

GIPAP

The international patient assistance programme, GIPAP is open in about 80 countries. As of November 30, 2007 the total number of patients reached was 19,378.

GIPAP

Survey

Help us improve Glivec.com. Please take our short survey.

TAKE SURVEY